1. Abdelhamid H Elgazzar, Saud Alenezi (Eds). A concise guide to nuclear medicine. Second Edition

   • Luigi Mansi

   Book Review 13 January 2021 Pages: 955 - 955

2. The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection

   • Abass Alavi
   • Thomas J. Werner
   • Ali Gholamrezanezhad

   Editorial 08 January 2021 Pages: 956 - 962

   

3. [⁶⁸Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging

   • Rutger Mahieu
   • Gerard C. Krijger
   • Bart de Keizer

   Editorial 06 November 2020 Pages: 963 - 965

4. Brain insulin sensitivity is linked to body fat distribution—the positron emission tomography perspective

   • Eleni Rebelos
   • Lauri Nummenmaa
   • Pirjo Nuutila

   Letter to the Editor Open access 07 October 2020 Pages: 966 - 968

   

5. In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers?

   • Varvara Valotassiou
   • George Angelidis
   • Panagiotis Georgoulias

   Letter to the Editor 20 October 2020 Pages: 969 - 971

6. Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy

   • Patrycja Guzik
   • Martina Benešová
   • Cristina Müller

   Original Article Open access 15 October 2020 Pages: 972 - 983

   

7. Promising potential of [¹⁷⁷Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model

   • Patrycja Guzik
   • Klaudia Siwowska
   • Cristina Müller

   Original Article Open access 19 October 2020 Pages: 984 - 994

   

8. A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET

   • Pavel Nikulin
   • Frank Hofheinz
   • Jörg van den Hoff

   Original Article Open access 01 October 2020 Pages: 995 - 1004

   

9. Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials

   • Bastien Jamet
   • Ludivine Morvan
   • Thomas Carlier

   Original Article 02 October 2020 Pages: 1005 - 1015

   

10. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM

    • Riemer H. J. A. Slart
    • Andor W. J. M. Glaudemans
    • the European Association of Nuclear Medicine (EANM)

    Guidelines Open access 27 October 2020 Pages: 1016 - 1039

11. EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging

    • Roberto Sciagrà
    • Mark Lubberink
    • Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)

    Guidelines Open access 02 November 2020 Pages: 1040 - 1069

    

12. Multiparametric PET and MRI of myocardial damage after myocardial infarction: correlation of integrin αvβ3 expression and myocardial blood flow

    • Marcus R. Makowski
    • Christoph Rischpler
    • Ambros J. Beer

    Original Article Open access 24 September 2020 Pages: 1070 - 1080

    

13. Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension

    • Armin Frille
    • Michael Rullmann
    • Hans-Juergen Seyfarth

    Original Article Open access 03 October 2020 Pages: 1081 - 1092

    

14. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases

    • Mona-Lisa Malarte
    • Agneta Nordberg
    • Laetitia Lemoine

    Original Article Open access 24 September 2020 Pages: 1093 - 1102

    

15. Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [¹⁸F] fluspidine and [¹⁸F] fallypride PET study

    • Igor D. Grachev
    • Philipp M. Meyer
    • Osama Sabri

    Original Article Open access 29 September 2020 Pages: 1103 - 1115

    

16. Visual interpretation of [¹⁸F]Florbetaben PET supported by deep learning–based estimation of amyloid burden

    • Ji-Young Kim
    • Dongkyu Oh
    • Dong Soo Lee

    Original Article 29 September 2020 Pages: 1116 - 1123

    

17. Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a ¹⁸F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study

    • Antonio Canosa
    • Andrea Calvo
    • Adriano Chiò

    Original Article Open access 07 October 2020 Pages: 1124 - 1133

    

18. Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version)

    • Xiaoli Lan
    • Yu Long
    • Yangminghui Song

    Guidelines 04 January 2021 Pages: 1134 - 1143

    

19. Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma

    • G. Manson
    • P. Brice
    • Roch Houot

    Original Article 28 August 2020 Pages: 1144 - 1153

    

20. ¹⁸F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study

    • Julian Kirchner
    • Vaios Hatzoglou
    • Eli L. Diamond

    Original Article Open access 15 October 2020 Pages: 1154 - 1165

    

21. IntraOmmaya compartmental radioimmunotherapy using ¹³¹I-omburtamab—pharmacokinetic modeling to optimize therapeutic index

    • Rahul S. Yerrabelli
    • Ping He
    • Nai-Kong V. Cheung

    Original Article 13 October 2020 Pages: 1166 - 1177

    

22. Improved cancer detection in Waldeyer’s tonsillar ring by ⁶⁸Ga-FAPI PET/CT imaging

    • S. Serfling
    • Y. Zhi
    • A. Scherzad

    Original Article Open access 15 October 2020 Pages: 1178 - 1187

    

23. EANM/SNMMI practice guideline for [¹⁸F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0

    • Judit A. Adam
    • Annika Loft
    • Wouter V. Vogel

    Guidelines Open access 04 December 2020 Pages: 1188 - 1199

24. PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis

    • Robert Seifert
    • Katharina Kessel
    • Kambiz Rahbar

    Original Article Open access 24 September 2020 Pages: 1200 - 1210

    

25. Optimal ⁶⁸Ga-PSMA and ¹⁸F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer

    • Cédric Draulans
    • Robin De Roover
    • Karin Haustermans

    Original Article 06 October 2020 Pages: 1211 - 1218

    

26. Improved oncological outcome after radical prostatectomy in patients staged with ⁶⁸Ga-PSMA-11 PET: a single-center retrospective cohort comparison

    • Daniela A. Ferraro
    • Fabienne Lehner
    • Irene A. Burger

    Original Article Open access 19 October 2020 Pages: 1219 - 1228

    

27. Safety and tolerability of ⁶⁸Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use

    • Marina Hodolic
    • Wen-Yu Wu
    • Feng Wang

    Short Communication 02 October 2020 Pages: 1229 - 1234

    

28. Improving staging of rectal cancer in the pelvis: the role of PET/MRI

    • Onofrio A. Catalano
    • Susanna I. Lee
    • Bruce Rosen

    Original Article 09 October 2020 Pages: 1235 - 1245

    

29. [⁶⁸Ga]Ga-tilmanocept PET/CT lymphoscintigraphy for sentinel lymph node detection in early-stage oral cavity carcinoma

    • Rutger Mahieu
    • Gerard C. Krijger
    • Bart de Keizer

    Image of the Month Open access 13 November 2020 Pages: 1246 - 1247

    

30. The superiority of [⁶⁸Ga]-FAPI-04 over [¹⁸F]-FDG PET/CT in imaging metastatic esophageal squamous cell carcinoma

    • Qiufang Liu
    • Si Shi
    • Shaoli Song

    Image of the Month 28 August 2020 Pages: 1248 - 1249

31. The use of ¹⁸F-FDG PET/CT to guide management of adrenal histoplasmosis over time

    • S. Parisien-La Salle
    • P. Morency-Potvin
    • I. Bourdeau

    Image of the Month 31 August 2020 Pages: 1250 - 1251

    

32. 18F-FDG simultaneous PET/MR monitoring treatment response of a Turcot syndrome case

    • Haiyan Wang
    • Qiaoyi Xue
    • Jun Zhao

    Image of the Month 02 September 2020 Pages: 1252 - 1253

    

33. [⁶⁸Ga]Ga-DOTA-FAPI-04 PET/CT imaging in a case of prostate cancer with shoulder arthritis

    • Tingting Xu
    • Yan Zhao
    • Yue Chen

    Image of the Month 08 September 2020 Pages: 1254 - 1255

    

34. An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [¹⁸F]FDG PET/CT

    • Kip E. Guja
    • Ryanne Brown
    • Carina Mari Aparici

    Image of the Month 12 September 2020 Pages: 1256 - 1257

    

35. A malignant birthmark detected by ¹⁸F-FDG PET/CT in a patient with esophageal cancer

    • Lijuan Wang
    • Yin Zhang

    Image of the Month 15 September 2020 Pages: 1258 - 1259

    

36. Image-based dosimetry for ²²⁵Ac-PSMA-I&T therapy using quantitative SPECT

    • A. Gosewisch
    • M. Schleske
    • G. Böning

    Image of the Month Open access 21 September 2020 Pages: 1260 - 1261

    

37. Response to ²²⁵Ac-PSMA-I&T after failure of long-term ¹⁷⁷Lu-PSMA RLT in mCRPC

    • Harun Ilhan
    • Astrid Gosewisch
    • Franz Josef Gildehaus

    Image of the Month Open access 22 September 2020 Pages: 1262 - 1263

    

38. Diffuse multiple organs uptake of ^99mTc-MDP on SPECT/CT

    • Maoqing Jiang
    • Ping Chen
    • Yu Chu

    Image of the Month 23 September 2020 Pages: 1264 - 1265

    

39. A rare case of cranial and spinal leptomeningeal dissemination of recurrent ethmoid carcinoma detected by [18F]-FDG PET/CT

    • Kota Yokoyama
    • Osamu Manabe
    • Ukihide Tateishi

    Image of the Month 25 September 2020 Pages: 1266 - 1267

    

40. Detection of pseudoprogression with [¹⁸F]-FDG-PET in a patient with pulmonary large cell neuroendocrine carcinoma who received anti-PD-1 treatment

    • Ou Yamaguchi
    • Kyoichi Kaira
    • Hiroshi Kagamu

    Image of the Month 22 October 2020 Pages: 1268 - 1270